The diagnostic accuracy (ACC) of CXCL8 (77%) was higher than CXCR2 (70%) and classical tumor markers, CEA (48%) and CA19-9 (66%), but lower than for CRP (79%). This evidence concerns the gene CXCL8 and neoplasm.